BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38174683)

  • 1. Exercise attenuates mitochondrial autophagy and neuronal degeneration in MPTP induced Parkinson's disease by regulating inflammatory pathway.
    Li Z; Lv H; Cui X; Di W; Cheng X; Liu J; Tripathi A
    Folia Neuropathol; 2023; 61(4):426-432. PubMed ID: 38174683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salidroside protects dopaminergic neurons by regulating the mitochondrial MEF2D-ND6 pathway in the MPTP/MPP
    Li T; Zhang W; Kang X; Yang R; Li R; Huang L; Chen J; Yang Q; Sun X
    J Neurochem; 2020 Apr; 153(2):276-289. PubMed ID: 31520529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective role of chloroquine via modulation of autophagy and neuroinflammation in MPTP-induced Parkinson's disease.
    Kartik S; Pal R; Chaudhary MJ; Nath R; Kumar M; Binwal M; Bawankule DU
    Inflammopharmacology; 2023 Apr; 31(2):927-941. PubMed ID: 36715843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endurance Exercise Mediates Neuroprotection Against MPTP-mediated Parkinson's Disease via Enhanced Neurogenesis, Antioxidant Capacity, and Autophagy.
    Jang Y; Kwon I; Song W; Cosio-Lima LM; Lee Y
    Neuroscience; 2018 May; 379():292-301. PubMed ID: 29559387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B.
    Guo B; Hu S; Zheng C; Wang H; Luo F; Li H; Cui W; Yang X; Cui G; Mak S; Choi TC; Ma ED; Wang Y; Lee SMY; Zhang Z; Han Y
    Neuropharmacology; 2017 Nov; 126():12-24. PubMed ID: 28807675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson's disease.
    Liu L; Peritore C; Ginsberg J; Shih J; Arun S; Donmez G
    Behav Brain Res; 2015 Mar; 281():215-21. PubMed ID: 25541039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease.
    Wu LK; Agarwal S; Kuo CH; Kung YL; Day CH; Lin PY; Lin SZ; Hsieh DJ; Huang CY; Chiang CY
    Phytomedicine; 2022 Sep; 104():154250. PubMed ID: 35752074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treadmill Exercise Attenuates α-Synuclein Levels by Promoting Mitochondrial Function and Autophagy Possibly via SIRT1 in the Chronic MPTP/P-Induced Mouse Model of Parkinson's Disease.
    Koo JH; Cho JY
    Neurotox Res; 2017 Oct; 32(3):473-486. PubMed ID: 28656548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain Selective Estrogen Treatment Protects Dopaminergic Neurons and Preserves Behavioral Function in MPTP-induced Mouse Model of Parkinson's Disease.
    Thadathil N; Xiao J; Hori R; Alway SE; Khan MM
    J Neuroimmune Pharmacol; 2021 Sep; 16(3):667-678. PubMed ID: 33221984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress.
    Nataraj J; Manivasagam T; Thenmozhi AJ; Essa MM
    Nutr Neurosci; 2016 Jul; 19(6):237-46. PubMed ID: 25730317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of mitochondrial phenotypes by endurance exercise contributes to neuroprotection against a MPTP-induced animal model of PD.
    Jang Y; Kwon I; Song W; Cosio-Lima LM; Taylor S; Lee Y
    Life Sci; 2018 Sep; 209():455-465. PubMed ID: 30144449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GSNOR deficiency attenuates MPTP-induced neurotoxicity and autophagy by facilitating CDK5 S-nitrosation in a mouse model of Parkinson's disease.
    Jiao L; Su LY; Liu Q; Luo R; Qiao X; Xie T; Yang LX; Chen C; Yao YG
    Free Radic Biol Med; 2022 Aug; 189():111-121. PubMed ID: 35918012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization.
    Lee Y; Park HR; Chun HJ; Lee J
    J Neurosci Res; 2015 May; 93(5):755-65. PubMed ID: 25677261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-124 regulates the expression of p62/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease.
    Yao L; Zhu Z; Wu J; Zhang Y; Zhang H; Sun X; Qian C; Wang B; Xie L; Zhang S; Lu G
    FASEB J; 2019 Jul; 33(7):8648-8665. PubMed ID: 30995872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective and anti-inflammatory effects of morin in a murine model of Parkinson's disease.
    Lee KM; Lee Y; Chun HJ; Kim AH; Kim JY; Lee JY; Ishigami A; Lee J
    J Neurosci Res; 2016 Oct; 94(10):865-78. PubMed ID: 27265894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-Aminopyridine Protects Nigral Dopaminergic Neurons in the MPTP Mouse Model of Parkinson's Disease.
    Shi L; Jia L; Wang Y; Xiu M; Xie J
    Neurochem Res; 2023 Jun; 48(6):1707-1715. PubMed ID: 36602724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Aminoethoxydiphenyl borate ameliorates mitochondrial dysfunctions in MPTP/MPP
    Vaidya B; Polepalli M; Sharma SS; Singh JN
    Mitochondrion; 2023 Mar; 69():95-103. PubMed ID: 36758857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperbaric Oxygen Therapy Improves Parkinson's Disease by Promoting Mitochondrial Biogenesis via the SIRT-1/PGC-1α Pathway.
    Hsu HT; Yang YL; Chang WH; Fang WY; Huang SH; Chou SH; Lo YC
    Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease.
    Prediger RD; Aguiar AS; Moreira EL; Matheus FC; Castro AA; Walz R; De Bem AF; Latini A; Tasca CI; Farina M; Raisman-Vozari R
    Curr Pharm Des; 2011; 17(5):489-507. PubMed ID: 21375482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.